Briacell Therapeutics Corp T.BCT

RE:Change of Board Members

[TriumphSpitSix]

Bondarenko shaking things up alright... for better or worse however is still TBD.

All new board members have their praises sang and their accomplishments lauded when they first come onboard. But they get a "best wishes" and maybe the heel of a boot on the way out.

For example, Martin Schmieg's appointment to the board in May 2016 was such a monumental event that he got an entire NR to himself touting all his accomplishments, hinting at the great things he would likewise do for Briacell... "raised $55 million in venture capital" for one company. Was the "financial architect" of another's sale for $4.2 billion. "[C]o-developed" another's "strategic plan which led to the company's acquisition by Merck & Co for $1.3 billion." I don't recall any accomplishments even remotely similar to these during his involvement with Briacell.

https://www.marketwired.com/press-release/briacell-adds-us-biotech-veteran-to-its-board-of-directors-2123214.htm

So, who knows... whether it's "progress" or just a reshuffle and lateral pass is up in the air. What are these new BOD members actually going TO DO for the company?

lakinisjuice1 wrote: Looks like Mr. Bondarenko wanted to change the board and made some changes.  Changes seem fine to me and look like progress.  As long as Dr. Williams is here that is key to me.  Any thoughts?

https://briacell.com/briacell-welcomes-biopharma-industry-experts-to-its-board-of-directors/